Contact
fibro-logo.png

ADA 2021: LIVERFAStTM Has Similar Performance to Liver Biopsy for the Screening of NASH Fibrosis in Type 2 Diabetes Mellitus (T2D).

Fibronostics_ADA-2021

Fibronostics is a healthcare technology company focused on transforming non-invasive solutions for early disease intervention.

  • 79 Science Park Drive #06-01/08, Cintech IV, Singapore Science Park I, Singapore 118264
  • + 65 6817 6290
  • 274 E. Eau Gallie Blvd., #346, Indian Harbour Beach, Florida 32937
  • 1-888-552-1603
  • service@fibronostics.com

Product

Science

Company

Contact Us

Linkedin Twitter

Fibronostics is a healthcare technology company focused on transforming non-invasive solutions for early disease intervention.

  • 79 Science Park Drive #06-01/08, Cintech IV, Singapore Science Park I, Singapore 118264
  • +65 6779 2521
  • service@fibronostics.com

© 2022, Fibronostics, All Rights Reserved.

© Copyright Fibronostics. All Rights Reserved